Pfizer raises 2026 revenue forecast to $62 billion-$64 billion
Bitget2026/11/03 11:54- Pfizer raised its 2026 revenue forecast to $62 billion to $64 billion from $60.5 billion to $62.5 billion.
- Adjusted diluted earnings guidance increased to $2.95 to $3.05 per share from $2.80 to $3.00.
- Projected adjusted R&D spending rose to $10.8 billion to $11.8 billion from $10.5 billion to $11.5 billion.
- Third-quarter revenue totaled $16.6 billion, roughly flat year over year; adjusted diluted earnings were $0.87 per share.
- Non-COVID revenue grew 7% operationally, offset by declines in COVID treatments, vaccines and other products.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barrick’s Marquee gold project faces hazy study timing
Japanese and South Korean stock markets open
Marvell Technology (MRVL.US) $115 billion "merger of the century" faces lukewarm reception! Stock has dropped over 40%, experts estimate only a 50% chance of completion
Marvell plans to acquire Lamington for 115 billions USD to strengthen its position in AI, but the probability of completion is only 50%. The two stocks have dropped by nearly 40% and about 35% respectively, with Chinese regulatory approval being the biggest uncertainty.
Crypto prices
More
